COVID-19 impact on thrombotic complications in cancer patients

QR Code

COVID-19 impact on thrombotic complications in cancer patients

Aim: to study the features of thrombotic complications in cancer patients during COVID-19 infection, and identify the most significant diagnostic and prognostic criteria.Materials and Methods. Within the framework of cohort non-randomized study, there were analyzed the course of coronavirus infectio...

Full description

Saved in:

Bibliographic Details
Main Authors:	A. V. Vorobev, S. E. Einullaeva, A. S. Borodulin, M. A. Shikina, S. A. Aliev, A. G. Solopova, V. N. Galkin, A. E. Ivanov, V. O. Bitsadze, J. Kh. Khizroeva, D. V. Blinov, J.-C. Gris, I. Elalamy, A. D. Makatsariya
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2024-07-01
Series:	Акушерство, гинекология и репродукция
Subjects:	covid-19 thrombotic complications oncological diseases vwf/adamts-13 axis pulmonary embolism pe deep vein thrombosis dvt systemic inflammatory response syndrome sirs
Online Access:	https://www.gynecology.su/jour/article/view/2088
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Functioning of the ADAMTS-13/vWF axis and its clinical significance
by: K. N. Grigoreva, et al.
Published: (2023-03-01)

Prognostic value of von Willebrand factor in clinical practice
by: K. N. Grigoreva, et al.
Published: (2022-11-01)

Immunothrombosis in cancer patients: contribution of neutrophil extracellular traps, ADAMTS-13 and von Willebrand factor
by: E. V. Slukhanchuk, et al.
Published: (2023-01-01)

COVID-19 and thrombotic microangiopathy
by: E. V. Sluhanchuk, et al.
Published: (2022-01-01)

Clinical significance of assessing ADAMTS-13 and von Willebrand factor level in COVID-19 convalescent pregnant women
by: N. R. Gashimova, et al.
Published: (2023-03-01)

Clinical significance of ADAMTS-13/vWF axis in pregnant women at different trimesters of gestation
by: K. N. Grigoreva, et al.
Published: (2023-05-01)

Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19
by: V. O. Bitsadze, et al.
Published: (2022-07-01)

Thrombotic Thrombocytopenic Purpura and Evans Syndrome: Validating and Exploring 20 Years of Routine Hospital Care
by: Lawrie DA, et al.
Published: (2025-06-01)

Neonatal thrombosis: risk factors and principles of prophylaxis
by: A. V. Vorobev, et al.
Published: (2021-09-01)

Clinical significance of measuring ADAMTS-13, its inhibitor and von Willebrand factor in obstetric and gynecological practice
by: K. N. Grigoreva, et al.
Published: (2021-03-01)

Management of Cancer-Associated Thrombosis: Unmet Needs and Future Perspectives
by: Anna Falanga, et al.
Published: (2021-07-01)

Comparative assessment of changes ADAMTS-13/von Willebrand factor axis in singleton and bichorial biamniotic pregnancy
by: F. Е. Yagubova, et al.
Published: (2024-09-01)

Neutrophil extracellular traps: a role in inflammation and dysregulated hemostasis as well as in patients with COVID-19 and severe obstetric pathology
by: A. D. Makatsariya, et al.
Published: (2021-09-01)

COVID-19 and systemic thrombotic syndromes
by: A. D. Makatsariya
Published: (2025-01-01)

100 years of Moschcowitz disease and thrombotic microangiopathy research: a look into the past and prospects
by: A. Yu. Shatilina, et al.
Published: (2024-09-01)

Thrombotic storm, hemostasis disorders and thromboinflammation in COVID-19
by: A. D. Makatsariya, et al.
Published: (2021-11-01)

THROMBOTIC MICROANGIOPATHY IN THE PATHOGENESIS OF OBSTETRIC COMPLICATIONS
by: S. V. Akinshina, et al.
Published: (2016-06-01)

Comparative estimation of the effectiveness of the Khorana, Vienna CATS, and TiC-Onco scores and the vWF/ADAMTS13 ratio in identifying a high risk of thrombotic complications in patients with malignant neoplasms
by: A. V. Vorobеv, et al.
Published: (2025-05-01)

CLINICAL CASE OF OBSTETRIC ATYPICAL HEMOLYTIC UREMIC SYNDROME
by: SVETLANA CH. Kara-Sal, et al.
Published: (2019-03-01)

Thrombotic Thrombocytopenic Purpura as a Rare Etiopathogenetic Cause of Cerebral Infarction and Extracerebral Thrombosis
by: А. R. Аvidzba, et al.
Published: (2021-08-01)

Genetic thrombophilia and antiphospholipid antibodies in women with early and late preeclampsia: a retrospective cohort study
by: A. S. Antonova, et al.
Published: (2025-03-01)

ADAM and ADAMTS Proteases in Hepatic Disorders
by: Dirk Schmidt-Arras, et al.
Published: (2019-02-01)

Maternal blood proteomics during relapse of early preeclampsia
by: M. G. Nikolaeva, et al.
Published: (2024-01-01)

HORMONE REPLACEMENT THERAPY AND PREVENTION OF THROMBOTIC COMPLICATIONS
by: A. V. Vorob'ev, et al.
Published: (2016-06-01)

Preeclampsia and venous thromboembolism
by: K. N. Grigoreva, et al.
Published: (2022-07-01)

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021-11-01)

Septic shock
by: V. O. Bitsadze, et al.
Published: (2020-09-01)

Effective Management of Carfilzomib-Induced Thrombotic Microangiopathy in Multiple Myeloma Using Eculizumab
by: Jennifer Kim, et al.
Published: (2025-06-01)

Clinical case of thrombotic microangiopathy in obstetric practice
by: M. N. Mochalova, et al.
Published: (2017-06-01)

Health and gene polymorphisms of the hemostatic system in newborn with thrombotic and ischemic events
by: T. V. Belousova, et al.
Published: (2018-07-01)

Clinical case of pregnancy complicated by thrombotic thrombocytopenic purpura
by: M. V. Semenova, et al.
Published: (2024-06-01)

Pancreatic Cancer Presenting with Thrombotic Thrombocytopenic Purpura: A Case Report and Review of Literature
by: Yeh-Chin Wang, et al.
Published: (2025-04-01)

Thrombophilia identified as a risk factor for thrombogenesis in cancer patients
by: A. V. Vorobev, et al.
Published: (2021-07-01)

Surgical management of nonbacterial thrombotic endocarditis in malignancy
by: Daisuke Kaneyuki, et al.
Published: (2017-05-01)

Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course
by: A. D. Makatsariya, et al.
Published: (2025-03-01)

Nystagmus as the presenting sign of thrombotic thrombocytopenic purpura
by: Iatissam El Belhadji, et al.
Published: (2025-06-01)

Predictors of Death in Comorbid Patients with Thrombotic Complications: a Single-Center Retrospective Cross- Sectional Study
by: A. A. Ivannikov, et al.
Published: (2024-01-01)

The relationships in the mother – placenta – child system in case of hematogenous thrombophilia and thrombotic state of readiness
by: T. V. Belousova, et al.
Published: (2017-01-01)

Fetal systemic inflammatory response syndrome, thromboinflammation and neonatal septic shock: pathogenesis, diagnostics and treatment
by: V. O. Bitsadze, et al.
Published: (2025-05-01)

High Levels of Soluble P-selectin, Neutrophil Extracellular Traps, and Myeloperoxidase as Risk Factor of Deep Vein Thrombosis in Malignancy Patients Receiving Platinum-Based Chemotherapy [version 2; peer review: 2 approved, 1 approved with reservations]
by: Ketut Suega, et al.
Published: (2025-07-01)